Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |